Simulation-guided pan-cancer analysis identifies a novel regulator of CpG island hypermethylation heterogeneity
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Xianglin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, the Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Tianqiao District, Jina…. Hauptthemen laut MEDLINE: DNA Methylation, CpG Islands, Neoplasms, Genetic Heterogeneity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
CpG island hypermethylation, a hallmark of cancer, exhibits substantial heterogeneity across tumors, presenting both opportunities and challenges for cancer diagnostics and therapeutics. While this heterogeneity offers potential for patient stratification to predict clinical outcomes and personalize treatments, it complicates the development of robust biomarkers for early detection. Understanding the mechanisms driving this heterogeneity is essential for advancing biomarker design. Here, simulation-based analyses demonstrate that tumor purity and the high prevalence of low epi-mutation samples significantly obscure the identification of negative, rather than positive, regulators of CpG island hypermethylation, limiting a comprehensive understanding of heterogeneity sources. By addressing these confounders, we identify impaired DNA methylation maintenance, as indicated by global hypomethylation levels, as the primary contributor to CpG island hypermethylation variability among known regulators. This finding is supported by integrative analyses of datasets from The Cancer Genome Atlas (TCGA) Pan-Cancer Atlas, Genomics of Drug Sensitivity in Cancer (GDSC1000) cancer cell lines, and epi-allele analyses of two independent whole-genome bisulfite sequencing cohorts, using a newly developed method, MeHist (https://github.com/vhang072/MeHist). Furthermore, we assess widely used hypermethylation biomarkers across ten cancer types and find that 65 out of 246 (26.4%) are significantly influenced by impaired methylation maintenance. Incorporating hypomethylation and hypermethylation markers improves the robustness of cancer detection, as validated across multiple plasma cell–free DNA datasets. In summary, our findings highlight the value of simulation-guided integrative analysis in mitigating confounding effects and identify impaired DNA methylation maintenance as a key regulator of CpG island hypermethylation heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, the Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Tianqiao District, Jinan, 250033, Shandong, China.
- Shandong Engineering & Technology Research Center for Tumor Marker Detection, Department of Clinical Laboratory, the Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Tianqiao Distri…
- Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory, Department of Clinical Laboratory, the Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Tianqiao Distr…
- Center of Intelligent Medicine, School of Control Science and Engineering, Shandong University, 17923 Jingshi Road, Lixia District, Jinan, 250061, Shandong, China.
- Department of Emergency Medical Center, the Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Tianqiao District, Jinan, 250033, Shandong, China.
- Department of Genetics, The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, 4515 McKinley Avenue, St. Louis, MO 63110, United States.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province
- National Key Research and Development Program of China
Zitieren
APA
Zhang, X., Zhang, W., Zhang, J., Lyu, X., Pan, H., Jia, T., Wang, T., Wang, X., & Guo, H. (2025). Simulation-guided pan-cancer analysis identifies a novel regulator of CpG island hypermethylation heterogeneity. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf252
Vancouver
Zhang X, Zhang W, Zhang J, Lyu X, Pan H, Jia T, et al. Simulation-guided pan-cancer analysis identifies a novel regulator of CpG island hypermethylation heterogeneity. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf252
BibTeX
@article{Zhang2025,
author = {Zhang, Xianglin and Zhang, Wei and Zhang, Jinyi and Lyu, Xiuhong and Pan, Haoran and Jia, Tianwei and Wang, Ting and Wang, Xiaowo and Guo, Haiyang},
title = {Simulation-guided pan-cancer analysis identifies a novel regulator of CpG island hypermethylation heterogeneity},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf252}
}
EUVIMED